# Intravenous Fluid Therapy for the Treatment of Emergency Department Patients With Migraine Headache

> **NCT02933060** · PHASE2,PHASE3 · COMPLETED · sponsor: **The Cooper Health System** · enrollment: 50 (actual)

## Conditions studied

- Migraine Headache

## Interventions

- **OTHER:** Normal saline (1000 mL)
- **OTHER:** Control

## Key facts

- **NCT ID:** NCT02933060
- **Lead sponsor:** The Cooper Health System
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01
- **Primary completion:** 2017-09-26
- **Final completion:** 2017-09-28
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2019-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02933060

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02933060, "Intravenous Fluid Therapy for the Treatment of Emergency Department Patients With Migraine Headache". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02933060. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*